Alpha 2.0
Login Register
» Articles » PMID: 33976519

SGLT-2 Inhibitors Beneficial Effects on Ventricular Repolarization May Be Protective Against Atrial Fibrillation Occurrence

Overview
Journal Acta Cardiol Sin
Date 2021 May 12
PMID 33976519
Citations 1
Authors
Dimitrios Patoulias
Affiliations
Soon will be listed here.
Citing Articles

Type Disparity in Sodium-Glucose Cotransporter-2 Inhibitors in Incidences of Renal Cell Carcinoma: A Propensity-Score-Matched Cohort Study.

Lin T, Wang W, Yang T, Jong G Cancers (Basel). 2024; 16(11).

PMID: 38893264 PMC: 11171380. DOI: 10.3390/cancers16112145.

References
1.
Cho M, Nam G, Kim Y, Kim J, Choi K, Kim Y . Clinical Implications of Ventricular Repolarization Parameters on Long-Term Risk of Atrial Fibrillation　- Longitudinal Follow-up Data From a General Ambulatory Korean Population. Circ J. 2020; 84(7):1067-1074. DOI: 10.1253/circj.CJ-19-1151. View
2.
Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E . Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Diabetes Complications. 2018; 32(5):501-511. DOI: 10.1016/j.jdiacomp.2018.02.004. View
3.
Duran M, Ziyrek M, Alsancak Y . Effects of SGLT2 Inhibitors as an Add-on Therapy to Metformin on Electrocardiographic Indices of Ventricular Repolarization. Acta Cardiol Sin. 2020; 36(6):626-632. PMC: 7677636. DOI: 10.6515/ACS.202011_36(6).20200511A. View
4.
Zhang N, Gong M, Tse G, Zhang Z, Meng L, Yan B . Prolonged corrected QT interval in predicting atrial fibrillation: A systematic review and meta-analysis. Pacing Clin Electrophysiol. 2018; 41(3):321-327. DOI: 10.1111/pace.13292. View
5.
Patoulias D, Toumpourleka M, Papadopoulos C, Doumas M . Meta-analysis Evaluating the Risk of Atrial Fibrillation With Newer Antidiabetics Across the Cardiovascular and Renal Outcome Trials. Am J Cardiol. 2020; 139:139-141. DOI: 10.1016/j.amjcard.2020.10.030. View